| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phenols | 9 | 2018 | 107 | 3.280 |
Why?
|
| Testosterone | 7 | 2025 | 211 | 2.350 |
Why?
|
| Corticosterone | 13 | 2018 | 90 | 2.270 |
Why?
|
| Leydig Cells | 7 | 2025 | 10 | 1.940 |
Why?
|
| Adrenocortical Hyperfunction | 4 | 2018 | 5 | 1.870 |
Why?
|
| Zona Fasciculata | 8 | 2017 | 8 | 1.580 |
Why?
|
| Rats, Sprague-Dawley | 28 | 2025 | 1766 | 1.530 |
Why?
|
| Aldosterone | 6 | 2018 | 66 | 1.460 |
Why?
|
| Zona Reticularis | 6 | 2016 | 6 | 1.400 |
Why?
|
| Phosphoproteins | 12 | 2012 | 206 | 1.380 |
Why?
|
| Rats | 37 | 2025 | 3735 | 1.350 |
Why?
|
| Ghrelin | 4 | 2025 | 17 | 1.320 |
Why?
|
| Animals | 80 | 2025 | 16992 | 1.240 |
Why?
|
| Pregnenolone | 12 | 2017 | 17 | 1.190 |
Why?
|
| Zona Glomerulosa | 3 | 2017 | 3 | 1.170 |
Why?
|
| Nanotechnology | 11 | 2015 | 176 | 1.130 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2025 | 131 | 1.090 |
Why?
|
| Cystic Fibrosis | 8 | 2023 | 28 | 1.080 |
Why?
|
| Granulosa Cells | 4 | 2012 | 44 | 1.070 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 2 | 2018 | 16 | 1.060 |
Why?
|
| Aminopyridines | 2 | 2018 | 26 | 1.040 |
Why?
|
| Sulfonamides | 2 | 2018 | 91 | 1.000 |
Why?
|
| Milk, Human | 6 | 2024 | 51 | 0.920 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2025 | 92 | 0.860 |
Why?
|
| Progesterone | 7 | 2012 | 121 | 0.830 |
Why?
|
| Fluorescent Dyes | 4 | 2014 | 182 | 0.770 |
Why?
|
| Pseudomonas Infections | 6 | 2023 | 23 | 0.770 |
Why?
|
| Bacteria | 9 | 2024 | 293 | 0.740 |
Why?
|
| Nanostructures | 8 | 2018 | 161 | 0.740 |
Why?
|
| Digitoxin | 2 | 2021 | 7 | 0.730 |
Why?
|
| Pseudomonas aeruginosa | 6 | 2023 | 63 | 0.710 |
Why?
|
| Food Deprivation | 2 | 2017 | 33 | 0.710 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2015 | 587 | 0.690 |
Why?
|
| Antineoplastic Agents | 10 | 2018 | 1019 | 0.680 |
Why?
|
| Nanoparticles | 11 | 2018 | 460 | 0.680 |
Why?
|
| Radioimmunoassay | 6 | 2016 | 70 | 0.680 |
Why?
|
| Neoplasms | 11 | 2020 | 1377 | 0.670 |
Why?
|
| Male | 45 | 2025 | 23409 | 0.670 |
Why?
|
| Cells, Cultured | 14 | 2018 | 1621 | 0.640 |
Why?
|
| Immunotoxins | 3 | 2017 | 13 | 0.630 |
Why?
|
| Drug Resistance, Neoplasm | 8 | 2017 | 307 | 0.610 |
Why?
|
| Transferrin | 4 | 2017 | 38 | 0.580 |
Why?
|
| Cell Differentiation | 3 | 2017 | 638 | 0.580 |
Why?
|
| Spleen | 2 | 2016 | 204 | 0.580 |
Why?
|
| Female | 49 | 2024 | 24698 | 0.570 |
Why?
|
| Adrenocorticotropic Hormone | 8 | 2017 | 27 | 0.570 |
Why?
|
| Dehydroepiandrosterone | 2 | 2008 | 10 | 0.560 |
Why?
|
| Luminescent Measurements | 2 | 2008 | 26 | 0.560 |
Why?
|
| Cyclic AMP | 6 | 2020 | 127 | 0.560 |
Why?
|
| Amphetamine | 2 | 2015 | 21 | 0.550 |
Why?
|
| Humans | 79 | 2024 | 43102 | 0.530 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 8 | 2017 | 19 | 0.530 |
Why?
|
| Caloric Restriction | 1 | 2017 | 34 | 0.510 |
Why?
|
| Adiposity | 1 | 2018 | 157 | 0.510 |
Why?
|
| Sodium | 1 | 2017 | 102 | 0.510 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2017 | 347 | 0.510 |
Why?
|
| Maternal Exposure | 2 | 2014 | 57 | 0.500 |
Why?
|
| Breast Neoplasms | 10 | 2016 | 1723 | 0.490 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 415 | 0.490 |
Why?
|
| Cell Line, Tumor | 22 | 2020 | 2676 | 0.480 |
Why?
|
| Feces | 5 | 2024 | 132 | 0.470 |
Why?
|
| Nanomedicine | 6 | 2015 | 52 | 0.470 |
Why?
|
| Dopamine | 2 | 2015 | 275 | 0.470 |
Why?
|
| Sputum | 6 | 2019 | 22 | 0.470 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 8 | 2017 | 10 | 0.470 |
Why?
|
| Endocrine Disruptors | 2 | 2014 | 44 | 0.460 |
Why?
|
| Metal Nanoparticles | 6 | 2014 | 230 | 0.450 |
Why?
|
| Adipose Tissue | 6 | 2018 | 182 | 0.450 |
Why?
|
| Plant Extracts | 2 | 2009 | 302 | 0.440 |
Why?
|
| Head and Neck Neoplasms | 3 | 2015 | 81 | 0.430 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 256 | 0.430 |
Why?
|
| Pregnancy | 8 | 2024 | 1772 | 0.420 |
Why?
|
| Gastric Acid | 2 | 2004 | 11 | 0.420 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 384 | 0.410 |
Why?
|
| Mice | 21 | 2022 | 6644 | 0.410 |
Why?
|
| Drug Delivery Systems | 5 | 2016 | 277 | 0.400 |
Why?
|
| Molecular Imaging | 2 | 2013 | 30 | 0.400 |
Why?
|
| Pseudomonas syringae | 3 | 2019 | 11 | 0.390 |
Why?
|
| Cisplatin | 5 | 2013 | 98 | 0.390 |
Why?
|
| Glucosamine | 1 | 2012 | 7 | 0.380 |
Why?
|
| Steroidogenic Factor 1 | 2 | 2010 | 5 | 0.370 |
Why?
|
| Contrast Media | 3 | 2013 | 103 | 0.360 |
Why?
|
| Gold | 4 | 2014 | 156 | 0.360 |
Why?
|
| Evolution, Molecular | 3 | 2019 | 307 | 0.350 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 147 | 0.350 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2024 | 203 | 0.350 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 190 | 0.340 |
Why?
|
| Brain | 3 | 2015 | 1472 | 0.340 |
Why?
|
| Estrogens | 2 | 2014 | 203 | 0.340 |
Why?
|
| Propylthiouracil | 1 | 2010 | 3 | 0.340 |
Why?
|
| Gadolinium | 4 | 2011 | 30 | 0.330 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2010 | 9 | 0.330 |
Why?
|
| Drug Carriers | 4 | 2016 | 174 | 0.330 |
Why?
|
| Cetacea | 2 | 2020 | 4 | 0.330 |
Why?
|
| Oculomotor Muscles | 2 | 2020 | 14 | 0.320 |
Why?
|
| Nerve Growth Factor | 1 | 2010 | 29 | 0.320 |
Why?
|
| Phosphotransferases | 1 | 2010 | 36 | 0.320 |
Why?
|
| Catechin | 1 | 2010 | 39 | 0.320 |
Why?
|
| Physical Conditioning, Animal | 2 | 2016 | 33 | 0.310 |
Why?
|
| Hydroxycholesterols | 4 | 2011 | 18 | 0.310 |
Why?
|
| Indole Alkaloids | 1 | 2009 | 14 | 0.310 |
Why?
|
| Fullerenes | 4 | 2011 | 31 | 0.310 |
Why?
|
| Body Weight | 5 | 2016 | 429 | 0.310 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 55 | 0.310 |
Why?
|
| Quinazolines | 1 | 2009 | 38 | 0.300 |
Why?
|
| Biology | 1 | 2009 | 20 | 0.300 |
Why?
|
| Genetic Variation | 5 | 2020 | 430 | 0.300 |
Why?
|
| International Cooperation | 1 | 2009 | 52 | 0.300 |
Why?
|
| Congresses as Topic | 1 | 2009 | 50 | 0.300 |
Why?
|
| Magnetic Resonance Spectroscopy | 11 | 2020 | 301 | 0.300 |
Why?
|
| Mice, Nude | 9 | 2017 | 408 | 0.290 |
Why?
|
| Environmental Pollutants | 1 | 2011 | 201 | 0.290 |
Why?
|
| Mammary Glands, Animal | 1 | 2008 | 23 | 0.280 |
Why?
|
| Liver | 3 | 2018 | 511 | 0.280 |
Why?
|
| Microscopy, Confocal | 3 | 2010 | 224 | 0.280 |
Why?
|
| Disease Models, Animal | 4 | 2015 | 1596 | 0.280 |
Why?
|
| Cell Line | 6 | 2021 | 1410 | 0.280 |
Why?
|
| Breast Feeding | 4 | 2024 | 126 | 0.280 |
Why?
|
| Infrared Rays | 1 | 2008 | 21 | 0.270 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2008 | 29 | 0.270 |
Why?
|
| Cell Proliferation | 5 | 2021 | 1455 | 0.260 |
Why?
|
| Metagenome | 2 | 2021 | 31 | 0.260 |
Why?
|
| Angiotensin II | 3 | 2015 | 102 | 0.260 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2024 | 50 | 0.260 |
Why?
|
| Blood Glucose | 2 | 2006 | 389 | 0.260 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 60 | 0.260 |
Why?
|
| PPAR alpha | 2 | 2018 | 42 | 0.260 |
Why?
|
| Coix | 1 | 2006 | 1 | 0.250 |
Why?
|
| Blotting, Western | 4 | 2016 | 883 | 0.250 |
Why?
|
| Infant, Premature | 3 | 2024 | 134 | 0.250 |
Why?
|
| Anti-Bacterial Agents | 5 | 2023 | 432 | 0.250 |
Why?
|
| Physical Exertion | 1 | 2006 | 27 | 0.250 |
Why?
|
| Gastrointestinal Motility | 1 | 2006 | 20 | 0.250 |
Why?
|
| Physical Endurance | 1 | 2006 | 20 | 0.250 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 1092 | 0.240 |
Why?
|
| Lung | 4 | 2023 | 492 | 0.240 |
Why?
|
| Polymers | 4 | 2020 | 155 | 0.240 |
Why?
|
| Diabetes, Gestational | 2 | 2024 | 56 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 183 | 0.240 |
Why?
|
| Postpartum Period | 3 | 2021 | 92 | 0.240 |
Why?
|
| Lactic Acid | 1 | 2006 | 112 | 0.230 |
Why?
|
| Luteinizing Hormone | 1 | 2025 | 61 | 0.230 |
Why?
|
| Endocytosis | 3 | 2012 | 118 | 0.230 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 3 | 2010 | 7 | 0.230 |
Why?
|
| Pentagastrin | 1 | 2004 | 2 | 0.230 |
Why?
|
| Desoxycorticosterone | 3 | 2010 | 9 | 0.230 |
Why?
|
| Brain Ischemia | 2 | 2006 | 189 | 0.220 |
Why?
|
| Epithelial Cells | 1 | 2008 | 434 | 0.220 |
Why?
|
| Polyethylene Glycols | 3 | 2017 | 108 | 0.220 |
Why?
|
| Chorionic Gonadotropin | 4 | 2020 | 16 | 0.220 |
Why?
|
| Glucose | 1 | 2006 | 244 | 0.220 |
Why?
|
| Glucose Intolerance | 2 | 2021 | 40 | 0.220 |
Why?
|
| Mitochondria | 4 | 2012 | 523 | 0.220 |
Why?
|
| Phylogeny | 5 | 2021 | 769 | 0.220 |
Why?
|
| Digoxin | 2 | 2021 | 10 | 0.220 |
Why?
|
| Inflammation | 3 | 2021 | 758 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2009 | 1124 | 0.210 |
Why?
|
| Testis | 1 | 2025 | 207 | 0.210 |
Why?
|
| Chickens | 3 | 2022 | 161 | 0.200 |
Why?
|
| Dihydrotestosterone | 3 | 2011 | 28 | 0.200 |
Why?
|
| Dietary Supplements | 2 | 2022 | 213 | 0.200 |
Why?
|
| Nanospheres | 2 | 2020 | 7 | 0.200 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2021 | 245 | 0.190 |
Why?
|
| DNA, Ribosomal | 2 | 2022 | 39 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 5 | 2021 | 515 | 0.190 |
Why?
|
| Insulin | 1 | 2004 | 258 | 0.190 |
Why?
|
| Stomach Ulcer | 1 | 2002 | 8 | 0.190 |
Why?
|
| Hypoglycemic Agents | 1 | 2004 | 184 | 0.190 |
Why?
|
| Ovariectomy | 3 | 2017 | 127 | 0.190 |
Why?
|
| Pharmaceutical Preparations | 2 | 2014 | 94 | 0.190 |
Why?
|
| Sesquiterpenes | 1 | 2002 | 38 | 0.190 |
Why?
|
| Muramidase | 1 | 2002 | 30 | 0.190 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2022 | 4 | 0.190 |
Why?
|
| Digitalis Glycosides | 1 | 2002 | 1 | 0.180 |
Why?
|
| Mothers | 2 | 2024 | 215 | 0.180 |
Why?
|
| Luteal Cells | 1 | 2002 | 3 | 0.180 |
Why?
|
| Parasites | 2 | 2021 | 38 | 0.180 |
Why?
|
| Adenine | 1 | 2002 | 46 | 0.180 |
Why?
|
| Hippocampus | 2 | 2020 | 594 | 0.180 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 316 | 0.180 |
Why?
|
| Glutathione | 1 | 2002 | 171 | 0.180 |
Why?
|
| Intestines | 1 | 2021 | 71 | 0.180 |
Why?
|
| Micronutrients | 1 | 2021 | 45 | 0.180 |
Why?
|
| Biocompatible Materials | 2 | 2014 | 108 | 0.170 |
Why?
|
| Infant | 5 | 2024 | 1175 | 0.170 |
Why?
|
| Cell Cycle | 2 | 2021 | 346 | 0.170 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2021 | 24 | 0.170 |
Why?
|
| Immune System Diseases | 1 | 2021 | 21 | 0.170 |
Why?
|
| DNA, Bacterial | 6 | 2021 | 206 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2015 | 186 | 0.170 |
Why?
|
| Antigens | 1 | 2020 | 59 | 0.170 |
Why?
|
| Camptothecin | 2 | 2017 | 21 | 0.160 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 30 | 0.160 |
Why?
|
| Nanotubes | 2 | 2017 | 17 | 0.160 |
Why?
|
| Genome, Bacterial | 2 | 2019 | 139 | 0.160 |
Why?
|
| Delayed-Action Preparations | 1 | 2020 | 74 | 0.160 |
Why?
|
| Photochemotherapy | 2 | 2017 | 43 | 0.160 |
Why?
|
| Receptors, LH | 1 | 2020 | 5 | 0.160 |
Why?
|
| Flavonoids | 2 | 2011 | 100 | 0.160 |
Why?
|
| Prolactin | 2 | 2015 | 65 | 0.160 |
Why?
|
| Ethinyl Estradiol | 1 | 2020 | 11 | 0.160 |
Why?
|
| Delivery, Obstetric | 1 | 2020 | 48 | 0.160 |
Why?
|
| Signal Transduction | 4 | 2018 | 2157 | 0.160 |
Why?
|
| Orbit | 1 | 2019 | 11 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2012 | 192 | 0.160 |
Why?
|
| Biological Transport | 2 | 2018 | 204 | 0.160 |
Why?
|
| Fluorescence | 3 | 2014 | 118 | 0.160 |
Why?
|
| Immunity | 1 | 2020 | 61 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2018 | 98 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 245 | 0.150 |
Why?
|
| Fungi | 2 | 2021 | 106 | 0.150 |
Why?
|
| Sirtuins | 1 | 2019 | 14 | 0.150 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2019 | 1 | 0.150 |
Why?
|
| beta-Lactams | 1 | 2019 | 2 | 0.150 |
Why?
|
| beta-Lactam Resistance | 1 | 2019 | 4 | 0.150 |
Why?
|
| Helminths | 1 | 2018 | 2 | 0.150 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2018 | 5 | 0.150 |
Why?
|
| Burkholderia cepacia complex | 1 | 2018 | 1 | 0.150 |
Why?
|
| Sarcoma, Kaposi | 1 | 2019 | 23 | 0.150 |
Why?
|
| Burkholderia Infections | 1 | 2018 | 3 | 0.150 |
Why?
|
| Herpesvirus 8, Human | 1 | 2019 | 25 | 0.150 |
Why?
|
| Berberine | 1 | 2018 | 9 | 0.150 |
Why?
|
| Escherichia coli | 3 | 2009 | 460 | 0.150 |
Why?
|
| Antioxidants | 1 | 2002 | 443 | 0.150 |
Why?
|
| Immediate-Early Proteins | 1 | 2019 | 49 | 0.140 |
Why?
|
| Tissue Distribution | 3 | 2015 | 240 | 0.140 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 41 | 0.140 |
Why?
|
| DNA, Fungal | 1 | 2018 | 49 | 0.140 |
Why?
|
| Interleukin-2 | 1 | 2018 | 91 | 0.140 |
Why?
|
| Drug Resistance, Multiple | 3 | 2017 | 28 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 526 | 0.140 |
Why?
|
| Cytotoxins | 1 | 2018 | 11 | 0.140 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 90 | 0.140 |
Why?
|
| Pneumonia | 1 | 2019 | 61 | 0.140 |
Why?
|
| PPAR gamma | 1 | 2018 | 55 | 0.140 |
Why?
|
| Platinum | 1 | 2018 | 23 | 0.140 |
Why?
|
| Prodrugs | 1 | 2018 | 31 | 0.140 |
Why?
|
| Adipocytes | 1 | 2018 | 60 | 0.140 |
Why?
|
| Diet | 2 | 2021 | 826 | 0.140 |
Why?
|
| Virulence Factors | 1 | 2019 | 125 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2019 | 192 | 0.140 |
Why?
|
| Ecology | 1 | 2018 | 33 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 2 | 0.140 |
Why?
|
| Breast | 3 | 2016 | 139 | 0.140 |
Why?
|
| Symbiosis | 1 | 2018 | 46 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 38 | 0.130 |
Why?
|
| Enzyme Activation | 2 | 2010 | 462 | 0.130 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2017 | 23 | 0.130 |
Why?
|
| Anthropometry | 1 | 1997 | 97 | 0.130 |
Why?
|
| Oligodendroglia | 1 | 2017 | 27 | 0.130 |
Why?
|
| Viral Proteins | 1 | 2019 | 190 | 0.130 |
Why?
|
| Frontal Lobe | 1 | 2017 | 58 | 0.130 |
Why?
|
| Cell Membrane | 2 | 2013 | 403 | 0.130 |
Why?
|
| Acetyltransferases | 2 | 2019 | 27 | 0.130 |
Why?
|
| Porphyrins | 1 | 2017 | 57 | 0.130 |
Why?
|
| Brain Neoplasms | 2 | 2017 | 140 | 0.130 |
Why?
|
| Nanofibers | 1 | 2017 | 17 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 187 | 0.130 |
Why?
|
| Organ Size | 2 | 2016 | 170 | 0.120 |
Why?
|
| Mammography | 3 | 2008 | 212 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2017 | 74 | 0.120 |
Why?
|
| Orchiectomy | 1 | 2016 | 37 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2019 | 455 | 0.120 |
Why?
|
| Adrenal Glands | 1 | 2016 | 18 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 65 | 0.120 |
Why?
|
| Acrolein | 1 | 2016 | 17 | 0.120 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 386 | 0.120 |
Why?
|
| Infant, Newborn | 4 | 2024 | 972 | 0.120 |
Why?
|
| Organoplatinum Compounds | 2 | 2013 | 19 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2015 | 12 | 0.120 |
Why?
|
| Adiponectin | 1 | 2016 | 59 | 0.120 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 129 | 0.120 |
Why?
|
| Holoprosencephaly | 1 | 2015 | 5 | 0.120 |
Why?
|
| Receptors, Transferrin | 3 | 2017 | 15 | 0.120 |
Why?
|
| Carbazoles | 1 | 2016 | 49 | 0.120 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 495 | 0.120 |
Why?
|
| Body Composition | 4 | 2001 | 159 | 0.120 |
Why?
|
| Photosensitizing Agents | 1 | 2016 | 56 | 0.120 |
Why?
|
| Surface-Active Agents | 1 | 2015 | 46 | 0.120 |
Why?
|
| Neuregulin-1 | 1 | 2015 | 26 | 0.120 |
Why?
|
| Plant Roots | 1 | 2018 | 180 | 0.120 |
Why?
|
| Face | 1 | 2015 | 40 | 0.110 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 61 | 0.110 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2014 | 3 | 0.110 |
Why?
|
| Canada | 3 | 2021 | 163 | 0.110 |
Why?
|
| Adult | 10 | 2024 | 13872 | 0.110 |
Why?
|
| Genotype | 5 | 2018 | 800 | 0.110 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2014 | 4 | 0.110 |
Why?
|
| Gene Expression | 2 | 2015 | 701 | 0.110 |
Why?
|
| Calcium | 2 | 2011 | 491 | 0.110 |
Why?
|
| Rats, Wistar | 5 | 2011 | 283 | 0.110 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 239 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 2 | 2018 | 107 | 0.110 |
Why?
|
| Hypothyroidism | 1 | 2014 | 26 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 299 | 0.110 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2014 | 55 | 0.110 |
Why?
|
| Myoblasts | 1 | 2014 | 30 | 0.110 |
Why?
|
| Time Factors | 5 | 2017 | 1857 | 0.100 |
Why?
|
| Muntjacs | 1 | 2013 | 1 | 0.100 |
Why?
|
| Curcumin | 1 | 2015 | 118 | 0.100 |
Why?
|
| Chemotaxis | 2 | 1986 | 68 | 0.100 |
Why?
|
| Osteopontin | 1 | 2014 | 46 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2014 | 107 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 296 | 0.100 |
Why?
|
| DNA Glycosylases | 1 | 2013 | 17 | 0.100 |
Why?
|
| Selection, Genetic | 3 | 2020 | 75 | 0.100 |
Why?
|
| Apoptosis | 5 | 2018 | 1568 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1271 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2018 | 536 | 0.100 |
Why?
|
| Cell Survival | 5 | 2015 | 945 | 0.100 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 201 | 0.100 |
Why?
|
| Cytochromes c | 1 | 2012 | 48 | 0.100 |
Why?
|
| DNA | 1 | 2016 | 592 | 0.100 |
Why?
|
| Drugs, Chinese Herbal | 2 | 2009 | 19 | 0.100 |
Why?
|
| Optical Devices | 1 | 2012 | 4 | 0.100 |
Why?
|
| Hyperthermia, Induced | 1 | 2012 | 28 | 0.100 |
Why?
|
| Adaptation, Biological | 3 | 2019 | 29 | 0.100 |
Why?
|
| Aorta, Abdominal | 2 | 2011 | 17 | 0.090 |
Why?
|
| Spheroids, Cellular | 1 | 2012 | 37 | 0.090 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2012 | 25 | 0.090 |
Why?
|
| Kinetics | 2 | 2012 | 695 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2021 | 1759 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2014 | 383 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2012 | 14 | 0.090 |
Why?
|
| Reactive Oxygen Species | 3 | 2012 | 532 | 0.090 |
Why?
|
| Liposomes | 3 | 2008 | 132 | 0.090 |
Why?
|
| Endometriosis | 1 | 2013 | 83 | 0.090 |
Why?
|
| Reproductive Control Agents | 1 | 2011 | 1 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 4 | 2017 | 694 | 0.090 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2012 | 57 | 0.090 |
Why?
|
| Nanocapsules | 1 | 2011 | 19 | 0.090 |
Why?
|
| Vasoconstriction | 1 | 2011 | 42 | 0.090 |
Why?
|
| Cytoskeleton | 1 | 2012 | 114 | 0.090 |
Why?
|
| Cross Reactions | 1 | 2011 | 87 | 0.090 |
Why?
|
| Nanotubes, Carbon | 1 | 2012 | 87 | 0.090 |
Why?
|
| Crystallization | 1 | 2011 | 88 | 0.090 |
Why?
|
| Rabbits | 1 | 2011 | 278 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2021 | 1600 | 0.090 |
Why?
|
| Potassium | 1 | 2011 | 109 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2018 | 986 | 0.090 |
Why?
|
| Nylons | 1 | 2010 | 2 | 0.080 |
Why?
|
| Methacrylates | 1 | 2010 | 6 | 0.080 |
Why?
|
| Microtubules | 1 | 2012 | 121 | 0.080 |
Why?
|
| Cell Extracts | 1 | 2010 | 16 | 0.080 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 2010 | 3 | 0.080 |
Why?
|
| Cell Fractionation | 1 | 2010 | 29 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2011 | 165 | 0.080 |
Why?
|
| Arabidopsis | 1 | 2012 | 103 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 31 | 0.080 |
Why?
|
| Oxidative Stress | 3 | 2012 | 1003 | 0.080 |
Why?
|
| Polyesters | 1 | 2010 | 28 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 140 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 62 | 0.080 |
Why?
|
| Purines | 1 | 2010 | 40 | 0.080 |
Why?
|
| PC12 Cells | 1 | 2010 | 93 | 0.080 |
Why?
|
| Neurites | 1 | 2010 | 40 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2021 | 1546 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 197 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 234 | 0.080 |
Why?
|
| Indoles | 1 | 2011 | 187 | 0.080 |
Why?
|
| Metagenomics | 2 | 2021 | 46 | 0.080 |
Why?
|
| Evodia | 1 | 2009 | 2 | 0.080 |
Why?
|
| Dopamine Agents | 1 | 2009 | 28 | 0.080 |
Why?
|
| Transfection | 3 | 2017 | 532 | 0.080 |
Why?
|
| Quinazolinones | 1 | 2009 | 10 | 0.080 |
Why?
|
| Obesity | 1 | 1997 | 1151 | 0.080 |
Why?
|
| Water Pollutants, Chemical | 1 | 2011 | 171 | 0.080 |
Why?
|
| Benzofurans | 1 | 2009 | 22 | 0.070 |
Why?
|
| Automation | 1 | 2009 | 22 | 0.070 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 37 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 1180 | 0.070 |
Why?
|
| beta-Lactamases | 1 | 2009 | 34 | 0.070 |
Why?
|
| Cholesterol | 1 | 2010 | 232 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2015 | 518 | 0.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2008 | 9 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2008 | 36 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2008 | 10 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1542 | 0.070 |
Why?
|
| Caseins | 1 | 2008 | 15 | 0.070 |
Why?
|
| Escherichia coli Infections | 1 | 2009 | 45 | 0.070 |
Why?
|
| China | 1 | 2009 | 229 | 0.070 |
Why?
|
| Corpus Striatum | 1 | 2009 | 121 | 0.070 |
Why?
|
| Statistics as Topic | 2 | 2006 | 123 | 0.070 |
Why?
|
| Diffusion | 2 | 2012 | 63 | 0.070 |
Why?
|
| Recombination, Genetic | 2 | 2019 | 95 | 0.070 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 64 | 0.070 |
Why?
|
| Janus Kinase 2 | 1 | 2008 | 36 | 0.070 |
Why?
|
| Swine | 3 | 2001 | 212 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 458 | 0.070 |
Why?
|
| STAT5 Transcription Factor | 1 | 2008 | 49 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2008 | 25 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 458 | 0.070 |
Why?
|
| Hospitals, University | 1 | 2008 | 39 | 0.070 |
Why?
|
| Steroids | 1 | 2008 | 45 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 575 | 0.070 |
Why?
|
| Organometallic Compounds | 1 | 2008 | 71 | 0.070 |
Why?
|
| Culture Media | 1 | 2008 | 96 | 0.070 |
Why?
|
| Whole Body Imaging | 1 | 2008 | 25 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2020 | 388 | 0.070 |
Why?
|
| Estradiol | 1 | 2009 | 268 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 74 | 0.070 |
Why?
|
| Luciferases | 1 | 2008 | 71 | 0.070 |
Why?
|
| Exocytosis | 1 | 2008 | 49 | 0.070 |
Why?
|
| Gestational Age | 2 | 2020 | 200 | 0.070 |
Why?
|
| Biodiversity | 2 | 2021 | 111 | 0.070 |
Why?
|
| Calcium Signaling | 1 | 2008 | 107 | 0.060 |
Why?
|
| Molecular Probes | 1 | 2007 | 23 | 0.060 |
Why?
|
| Child | 3 | 2023 | 3443 | 0.060 |
Why?
|
| Optics and Photonics | 1 | 2007 | 34 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2007 | 114 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 114 | 0.060 |
Why?
|
| Magnetics | 1 | 2007 | 43 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 259 | 0.060 |
Why?
|
| Peptide Hormones | 1 | 2006 | 19 | 0.060 |
Why?
|
| Acetone | 1 | 2006 | 7 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 508 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 108 | 0.060 |
Why?
|
| Computer Simulation | 3 | 2018 | 408 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 105 | 0.060 |
Why?
|
| Smoking | 1 | 2013 | 1024 | 0.060 |
Why?
|
| Reperfusion Injury | 1 | 2006 | 58 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 196 | 0.060 |
Why?
|
| Young Adult | 4 | 2021 | 5080 | 0.060 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2006 | 98 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 436 | 0.060 |
Why?
|
| Doxorubicin | 2 | 2017 | 97 | 0.060 |
Why?
|
| Cluster Analysis | 3 | 2015 | 207 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1063 | 0.060 |
Why?
|
| Prevalence | 2 | 2021 | 1612 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 1869 | 0.060 |
Why?
|
| Gastric Acidity Determination | 1 | 2004 | 3 | 0.060 |
Why?
|
| Genetic Vectors | 2 | 2017 | 165 | 0.060 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2004 | 3 | 0.060 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2005 | 43 | 0.060 |
Why?
|
| Injections, Intravenous | 2 | 2002 | 67 | 0.060 |
Why?
|
| Connexin 43 | 1 | 2005 | 41 | 0.060 |
Why?
|
| Subtraction Technique | 1 | 2004 | 7 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 2004 | 7 | 0.060 |
Why?
|
| Gap Junctions | 1 | 2005 | 49 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 280 | 0.050 |
Why?
|
| Pattern Recognition, Automated | 1 | 2004 | 32 | 0.050 |
Why?
|
| Repressor Proteins | 2 | 2019 | 273 | 0.050 |
Why?
|
| Membrane Fluidity | 1 | 2004 | 10 | 0.050 |
Why?
|
| Cell Death | 2 | 2015 | 278 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2015 | 184 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2023 | 17 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 216 | 0.050 |
Why?
|
| Brain Infarction | 1 | 2003 | 22 | 0.050 |
Why?
|
| Models, Biological | 4 | 2012 | 712 | 0.050 |
Why?
|
| Carcinoma | 1 | 2004 | 108 | 0.050 |
Why?
|
| Colony-Forming Units Assay | 2 | 2015 | 9 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 218 | 0.050 |
Why?
|
| Hep G2 Cells | 2 | 2014 | 63 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1070 | 0.050 |
Why?
|
| Hydrochloric Acid | 1 | 2002 | 3 | 0.050 |
Why?
|
| Pyloric Antrum | 1 | 2002 | 6 | 0.050 |
Why?
|
| Age Factors | 2 | 2017 | 1154 | 0.050 |
Why?
|
| Lipid Peroxides | 1 | 2002 | 19 | 0.050 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 24 | 0.050 |
Why?
|
| Surface Properties | 2 | 2013 | 160 | 0.050 |
Why?
|
| Body Water | 2 | 2020 | 26 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 6081 | 0.050 |
Why?
|
| Food, Fortified | 1 | 2022 | 11 | 0.050 |
Why?
|
| Histamine | 1 | 2002 | 19 | 0.050 |
Why?
|
| Light | 3 | 2013 | 185 | 0.050 |
Why?
|
| Long-Term Care | 1 | 2023 | 55 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2002 | 31 | 0.050 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2003 | 78 | 0.050 |
Why?
|
| Exercise Therapy | 1 | 2003 | 87 | 0.050 |
Why?
|
| Gastric Mucosa | 1 | 2002 | 65 | 0.050 |
Why?
|
| Palatine Tonsil | 1 | 2022 | 7 | 0.050 |
Why?
|
| Phenanthridines | 1 | 2002 | 4 | 0.050 |
Why?
|
| Nifedipine | 1 | 2002 | 10 | 0.050 |
Why?
|
| Benzophenanthridines | 1 | 2002 | 14 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 49 | 0.050 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2002 | 3 | 0.050 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2002 | 13 | 0.050 |
Why?
|
| Ouabain | 1 | 2002 | 15 | 0.050 |
Why?
|
| Hormone Antagonists | 1 | 2002 | 13 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 65 | 0.050 |
Why?
|
| Mifepristone | 1 | 2002 | 34 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 29 | 0.050 |
Why?
|
| Oligosaccharides | 1 | 2021 | 29 | 0.040 |
Why?
|
| Alkaloids | 1 | 2002 | 46 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 175 | 0.040 |
Why?
|
| Aztreonam | 1 | 2021 | 1 | 0.040 |
Why?
|
| Ceftazidime | 1 | 2021 | 2 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 1081 | 0.040 |
Why?
|
| Algorithms | 1 | 2004 | 509 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2015 | 411 | 0.040 |
Why?
|
| Vitamins | 1 | 2021 | 81 | 0.040 |
Why?
|
| Prevotella | 1 | 2021 | 2 | 0.040 |
Why?
|
| Particle Size | 2 | 2012 | 272 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2020 | 18 | 0.040 |
Why?
|
| Cattle | 1 | 2022 | 498 | 0.040 |
Why?
|
| Tissue Fixation | 1 | 2020 | 19 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2024 | 1285 | 0.040 |
Why?
|
| Lipids | 2 | 2020 | 256 | 0.040 |
Why?
|
| Microwaves | 1 | 2020 | 29 | 0.040 |
Why?
|
| Zinc | 1 | 2021 | 131 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2012 | 90 | 0.040 |
Why?
|
| Maternal Age | 1 | 2020 | 33 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 147 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2020 | 75 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2020 | 63 | 0.040 |
Why?
|
| Body Size | 1 | 2020 | 49 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2013 | 159 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 37 | 0.040 |
Why?
|
| Protons | 1 | 2020 | 94 | 0.040 |
Why?
|
| Pituitary Gland, Anterior | 2 | 2014 | 12 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 251 | 0.040 |
Why?
|
| Linear Models | 1 | 2020 | 317 | 0.040 |
Why?
|
| Neurons | 1 | 2006 | 1263 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2020 | 144 | 0.040 |
Why?
|
| Malawi | 1 | 2018 | 10 | 0.040 |
Why?
|
| Phytohemagglutinins | 1 | 2018 | 13 | 0.040 |
Why?
|
| DNA, Protozoan | 1 | 2018 | 26 | 0.040 |
Why?
|
| Virus Latency | 1 | 2019 | 49 | 0.040 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2018 | 8 | 0.040 |
Why?
|
| Scattering, Radiation | 2 | 2013 | 43 | 0.040 |
Why?
|
| Genome | 1 | 2020 | 149 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2018 | 87 | 0.040 |
Why?
|
| Regression Analysis | 2 | 1997 | 490 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 135 | 0.040 |
Why?
|
| Oxygen | 2 | 2012 | 218 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2018 | 91 | 0.040 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 158 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 105 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2019 | 91 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2019 | 113 | 0.040 |
Why?
|
| Flurbiprofen | 1 | 2018 | 5 | 0.040 |
Why?
|
| DNA Replication | 1 | 2019 | 148 | 0.030 |
Why?
|
| United States | 1 | 2009 | 5205 | 0.030 |
Why?
|
| Lipid Peroxidation | 2 | 2008 | 140 | 0.030 |
Why?
|
| Skinfold Thickness | 1 | 1997 | 7 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 456 | 0.030 |
Why?
|
| Chlorophyllides | 1 | 2017 | 2 | 0.030 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2017 | 5 | 0.030 |
Why?
|
| Biological Assay | 1 | 2018 | 63 | 0.030 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2017 | 1 | 0.030 |
Why?
|
| Droughts | 1 | 2018 | 30 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 18 | 0.030 |
Why?
|
| Anisotropy | 1 | 2017 | 33 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 1997 | 76 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2017 | 19 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2012 | 1604 | 0.030 |
Why?
|
| Genomics | 1 | 2020 | 293 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2019 | 199 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 27 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2019 | 311 | 0.030 |
Why?
|
| Soil Microbiology | 1 | 2018 | 68 | 0.030 |
Why?
|
| Micelles | 1 | 2017 | 36 | 0.030 |
Why?
|
| Calcium Channels | 1 | 2017 | 73 | 0.030 |
Why?
|
| Models, Animal | 1 | 2017 | 151 | 0.030 |
Why?
|
| Vitamin E | 1 | 2017 | 62 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 968 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 333 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 1067 | 0.030 |
Why?
|
| Virus Replication | 1 | 2019 | 318 | 0.030 |
Why?
|
| Hela Cells | 2 | 2010 | 376 | 0.030 |
Why?
|
| Energy Metabolism | 2 | 2014 | 187 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 423 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 34 | 0.030 |
Why?
|
| Photobleaching | 1 | 2016 | 3 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 925 | 0.030 |
Why?
|
| Plasmids | 1 | 2017 | 244 | 0.030 |
Why?
|
| Ibuprofen | 1 | 1996 | 34 | 0.030 |
Why?
|
| Drug Resistance, Fungal | 1 | 2015 | 33 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 465 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 518 | 0.030 |
Why?
|
| Sequence Homology | 1 | 2015 | 35 | 0.030 |
Why?
|
| Sodium Cyanide | 1 | 1995 | 3 | 0.030 |
Why?
|
| Cadaver | 1 | 2015 | 40 | 0.030 |
Why?
|
| Water | 1 | 2018 | 316 | 0.030 |
Why?
|
| Astrocytes | 1 | 2017 | 244 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 21 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1082 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 863 | 0.030 |
Why?
|
| Microglia | 1 | 2017 | 208 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 145 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 140 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 934 | 0.030 |
Why?
|
| Breast Diseases | 2 | 1985 | 5 | 0.030 |
Why?
|
| Isoquinolines | 1 | 1995 | 55 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2014 | 8 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2015 | 76 | 0.030 |
Why?
|
| Fumarates | 1 | 2014 | 11 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2015 | 121 | 0.030 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2014 | 12 | 0.030 |
Why?
|
| Inorganic Chemicals | 1 | 2014 | 1 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 195 | 0.030 |
Why?
|
| Receptors, Ghrelin | 1 | 2014 | 2 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2014 | 104 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 70 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 146 | 0.030 |
Why?
|
| Growth Hormone | 1 | 2014 | 35 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2014 | 24 | 0.030 |
Why?
|
| Piperazines | 1 | 1995 | 120 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1995 | 124 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2014 | 36 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2014 | 49 | 0.030 |
Why?
|
| Isometric Contraction | 1 | 2014 | 25 | 0.030 |
Why?
|
| Asphyxia Neonatorum | 1 | 1994 | 5 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 1 | 1994 | 8 | 0.030 |
Why?
|
| Mathematics | 2 | 1986 | 57 | 0.030 |
Why?
|
| Microscopy, Scanning Tunneling | 1 | 2013 | 2 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 595 | 0.030 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2013 | 31 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 53 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 81 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 63 | 0.030 |
Why?
|
| Androstenedione | 1 | 2013 | 19 | 0.030 |
Why?
|
| Chemistry, Physical | 1 | 2013 | 50 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2014 | 154 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2013 | 64 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 188 | 0.030 |
Why?
|
| Taiwan | 1 | 2013 | 23 | 0.030 |
Why?
|
| Technology, Pharmaceutical | 1 | 2013 | 35 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 2013 | 61 | 0.030 |
Why?
|
| Brain Edema | 1 | 1994 | 64 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 161 | 0.030 |
Why?
|
| Sexual Behavior, Animal | 1 | 2013 | 64 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 160 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 97 | 0.020 |
Why?
|
| KB Cells | 1 | 2012 | 7 | 0.020 |
Why?
|
| Eating | 1 | 2014 | 167 | 0.020 |
Why?
|
| Reproduction | 1 | 2013 | 94 | 0.020 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2013 | 95 | 0.020 |
Why?
|
| Cell Respiration | 1 | 2012 | 35 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 296 | 0.020 |
Why?
|
| Alleles | 1 | 2014 | 352 | 0.020 |
Why?
|
| Electroencephalography | 1 | 1994 | 139 | 0.020 |
Why?
|
| Static Electricity | 1 | 2012 | 86 | 0.020 |
Why?
|
| Electron Transport | 1 | 2012 | 47 | 0.020 |
Why?
|
| Materials Testing | 1 | 2012 | 101 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 876 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2013 | 161 | 0.020 |
Why?
|
| Phytic Acid | 1 | 2012 | 3 | 0.020 |
Why?
|
| Turkeys | 1 | 1991 | 2 | 0.020 |
Why?
|
| RNA | 1 | 2014 | 266 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 1994 | 173 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 667 | 0.020 |
Why?
|
| Streptozocin | 1 | 2011 | 26 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2011 | 34 | 0.020 |
Why?
|
| Acetylation | 1 | 2012 | 107 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 780 | 0.020 |
Why?
|
| Arabidopsis Proteins | 1 | 2012 | 46 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2011 | 49 | 0.020 |
Why?
|
| Tubulin | 1 | 2012 | 96 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 2544 | 0.020 |
Why?
|
| Plant Diseases | 1 | 2012 | 65 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 592 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2010 | 29 | 0.020 |
Why?
|
| Toxicity Tests | 1 | 2010 | 44 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 1177 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 290 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2010 | 17 | 0.020 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2009 | 11 | 0.020 |
Why?
|
| Middle Aged | 3 | 2015 | 12222 | 0.020 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2009 | 59 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1989 | 9 | 0.020 |
Why?
|
| Catheterization | 1 | 1989 | 22 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2009 | 92 | 0.020 |
Why?
|
| Salvia miltiorrhiza | 1 | 2009 | 5 | 0.020 |
Why?
|
| Depsides | 1 | 2009 | 8 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2009 | 30 | 0.020 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2009 | 27 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2009 | 16 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2009 | 27 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 98 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2009 | 64 | 0.020 |
Why?
|
| Picrates | 1 | 2008 | 7 | 0.020 |
Why?
|
| Singlet Oxygen | 1 | 2008 | 6 | 0.020 |
Why?
|
| Hydroxyl Radical | 1 | 2008 | 14 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2008 | 41 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2009 | 67 | 0.020 |
Why?
|
| Hydrazines | 1 | 2008 | 22 | 0.020 |
Why?
|
| Caspases | 1 | 2009 | 148 | 0.020 |
Why?
|
| Superoxides | 1 | 2008 | 57 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2008 | 53 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 291 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 19 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2008 | 84 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 355 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2008 | 79 | 0.020 |
Why?
|
| District of Columbia | 1 | 2008 | 80 | 0.020 |
Why?
|
| Exercise | 1 | 2014 | 692 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 652 | 0.020 |
Why?
|
| Macrophages | 1 | 2011 | 529 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 138 | 0.020 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2006 | 5 | 0.020 |
Why?
|
| Microscopy, Scanning Probe | 1 | 2006 | 2 | 0.020 |
Why?
|
| K562 Cells | 1 | 2006 | 32 | 0.020 |
Why?
|
| Serine | 1 | 1986 | 79 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2006 | 18 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2006 | 68 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 291 | 0.010 |
Why?
|
| Thermography | 1 | 1984 | 3 | 0.010 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2004 | 11 | 0.010 |
Why?
|
| Cysts | 1 | 1984 | 10 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1984 | 59 | 0.010 |
Why?
|
| Californium | 1 | 1984 | 2 | 0.010 |
Why?
|
| Phosphates | 2 | 1995 | 54 | 0.010 |
Why?
|
| Physical Examination | 1 | 1984 | 45 | 0.010 |
Why?
|
| Brachytherapy | 1 | 1984 | 11 | 0.010 |
Why?
|
| Information Storage and Retrieval | 1 | 2004 | 35 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2005 | 97 | 0.010 |
Why?
|
| Calcinosis | 1 | 1984 | 62 | 0.010 |
Why?
|
| Pyrimidinones | 1 | 2004 | 15 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1984 | 135 | 0.010 |
Why?
|
| Clone Cells | 1 | 2004 | 50 | 0.010 |
Why?
|
| Isoxazoles | 1 | 2004 | 15 | 0.010 |
Why?
|
| Cyclic N-Oxides | 1 | 2004 | 19 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2004 | 66 | 0.010 |
Why?
|
| Risk | 1 | 1984 | 287 | 0.010 |
Why?
|
| Membrane Lipids | 1 | 2004 | 30 | 0.010 |
Why?
|
| Potassium Channels | 1 | 2004 | 80 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 222 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 195 | 0.010 |
Why?
|
| Glioma | 1 | 1984 | 96 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 311 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2004 | 134 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 224 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 611 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2004 | 112 | 0.010 |
Why?
|
| Muscles | 2 | 1993 | 82 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 26 | 0.010 |
Why?
|
| Elasticity | 1 | 1981 | 53 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 181 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 561 | 0.010 |
Why?
|
| Proteins | 2 | 1993 | 382 | 0.010 |
Why?
|
| Cell Movement | 1 | 1981 | 655 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1996 | 34 | 0.010 |
Why?
|
| Phosphorus Isotopes | 1 | 1995 | 8 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 1995 | 8 | 0.010 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1995 | 7 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1996 | 169 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1996 | 259 | 0.010 |
Why?
|
| Brain Damage, Chronic | 1 | 1994 | 5 | 0.010 |
Why?
|
| Intracranial Pressure | 1 | 1994 | 5 | 0.010 |
Why?
|
| Sheep | 1 | 1994 | 77 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1994 | 91 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1994 | 352 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1994 | 306 | 0.010 |
Why?
|
| Iliac Artery | 1 | 1989 | 8 | 0.000 |
Why?
|
| Renal Artery | 1 | 1989 | 7 | 0.000 |
Why?
|
| Calibration | 1 | 1989 | 63 | 0.000 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1985 | 2 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1985 | 62 | 0.000 |
Why?
|
| Aged | 1 | 1985 | 8214 | 0.000 |
Why?
|